Cite
MLA Citation
Hilary Bilyard et al.. “IMM-101, an immunotherapeutic agent in clinical development as an adjunctive treatment for pancreatic cancer.” Journal for immunotherapy of cancer, vol. 2, n.d., p. . http://access.bl.uk/ark:/81055/vdc_100137795279.0x000006